Insider Ledger Splits: Executives Cash Out of Large Caps While Chemours Board Buys the Dip
A cluster of Form 4 disclosures shows heavy selling at Allstate, Phillips 66 and Viasat, while four Chemours insiders committed more than $350,000 of personal capital — a rare, coordinated vote of confidence in a battered chemicals name.
Twenty-four hours of insider filings reveal a two-track market: senior executives at insurance, refining and satellite names monetizing equity into strength, while Chemours' president, co-president and two directors made concurrent open-market purchases. Cluster buying by multiple insiders at a single issuer is historically the more statistically meaningful signal.
- Investing.com — All NewsTidewater EVP Daniel Hudson sells $445,050 in common stockExternal ↗
- Investing.com — All NewsChemours co president Michael Foley buys $29,999 in stockExternal ↗
- Investing.com — All NewsChemours director Mary B Cranston acquires $94,950 in stockExternal ↗
- Investing.com — All NewsMagnolia Oil & Gas director Ropp buys $123,125 in stockExternal ↗
- Investing.com — All NewsChemours president Martinko buys $30,008 in company stockExternal ↗
- Investing.com — All NewsChemours director Alister Cowan buys $203,060 of company stockExternal ↗
- Investing.com — All NewsAvis Budget Group EVP sells $652,574 in company stockExternal ↗
- Investing.com — All NewsAllstate president John Dugenske sells $8.89m in company stockExternal ↗
- Investing.com — All NewsExtreme Networks director Raj Khanna sells $363,001 in stockExternal ↗
- Investing.com — All NewsPhillips 66 SVP and controller Kluppel sells $1.65m in stockExternal ↗
- Investing.com — All NewsViasat SVP Robert Blair sells $2.15m in common stockExternal ↗
- Investing.com — All NewsConsumers Bancorp director David Bickerton buys $6,205 in sharesExternal ↗
- Investing.com — All NewsStanley Black & Decker CAO Scot Greulach sells $105,164 in stockExternal ↗
Produced automatically by the INDY NEWS Desk from the public wire sources cited above, and checked against them before publication. Market commentary, not investment advice.